(Q34445601)

2 August 2017

Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process? (English)

1 reference

2 August 2017

0 references

Heiko Braak

1

1 reference

PubMed ID

25359108

2 August 2017

Kelly Del Tredici

series ordinal

2

1 reference

2 August 2017

31 October 2014

1 reference

2 August 2017

Acta Neuropathologica

1 reference

2 August 2017

128

1 reference

2 August 2017

6

1 reference

2 August 2017

767-772

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-014-1356-1

2 August 2017

0 references

cites work

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

FDG-PET and amyloid-PET imaging: the diverging paths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

Silver diagnosis in neuropathology: principles, practice and revised interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1356-1

10.1007/S00401-014-1356-1

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

25359108

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

25359108